The cleaning validation processes of companies manufacturing active ingredients continues to be at the forefront of concerns of federal regulators, especially to protect the health and well-being of consumers. Per cGMP and FDA guidelines, cleaning procedures must be repeatable, verifiable and recorded.
In recent times, numerous pharmaceutical companies have been publicly criticized for not properly cleaning their equipment that comes into contact with Active Pharmaceutical Ingredients (APIs) and thus contaminating other products that are manufactured by that machinery. These contaminated products can then be consumed by patients, potentially causing life-threatening complications. More than ever, it’s become essential for these pharmaceutical manufacturing companies to ensure the cleanliness of every piece of apparatus used in manufacturing these products.
Here’s how one multinational pharmaceutical company became GMP compliant whilst increasing production and reducing costs. Find out more by submitting the form below.
Access our previous white papers also available for download.
Come meet us at the ISPE CaSA 2023 Life Sciences Technology Conference– an elite event that allows participants to showcase the best of what our industry has to offer.
Come meet us at the 2022 ISPE Annual Meeting and Expo in Orlando. The exposition will be held at the Gaylord Palms Resort & Convention Center, in Orlando, FL, from Oct 31st-Nov 1st. We look forward to seeing you there!
In the world leading North American pharmaceutical and biotechnology markets, businesses expect high quality and cutting edge solutions with an equally superior level of local support and after-sales service:
For this reason, we are proud to announce a new partnership between Tema Sinergie and STEQ America.
